ADCT

ADC Therapeutics · USD

Market closed US (NYSE / Nasdaq) · 09:30–16:00 · Mon 17:08 · approx

Deep AI analysis (big model)

No deep analysis yet. Portfolio holdings are analysed automatically; for any other stock, click “Request deep AI analysis” above.

About ADC Therapeutics

ADC Therapeutics (ADCT) is a biopharmaceutical company focused on developing and commercializing antibody-drug conjugates for the treatment of hematologic cancers and solid tumors, operating within the Healthcare sector.

HealthcareBiotechnologyPharmaceuticals
TickerADCT
NameADC Therapeutics
CurrencyUSD
SectorHealthcare

Reputation

😎
How liked 50/100
From 0 recent analysed stories — 0 good · 0 bad · 0 neutral. Trend: stable.

Reputation builds as news about this company is analysed.

Price history & forecast

30-day forecast — Linear regression, Holt's exponential smoothing, and drift, plus a news-adjusted consensus (sentiment tilt +0.00). Estimates only, not advice.

Candlestick, volume & news sentiment

good bad neutral closed

Open/high/low/close candles with volume beneath; hover for OHLC, change and volume. Dots mark analysed news by sentiment; shaded bands are when the market was closed. Day and Week show intraday detail; Month+ show daily candles. Step through time with ‹ ›.

Forecast accuracy (backtested)

No scored forecasts yet. Every visit records the day's forecast; once those predicted dates pass, this table fills in with how each method actually did (1 snapshot(s) recorded so far, none matured yet).

Technical analysis

BEARISH
4.56
RSI (14)i
2.28
SMA 20i
3.19
SMA 50i
3.73
SMA 200i
4.26%
1di
0.62%
1wi
-69.91%
1mi
11.25%
30d voli
4.88
52w highi
0.88
52w lowi
-79.96%
from highi
-0.73
MACDi
Downtrend (50d below 200d)Oversold (RSI 5)MACD bearish crossover

Computed from 258 locally-stored price bars.

AI signals

  • SELL 85% · long_term 2026-06-08 10:12

    The stock has experienced a significant decline in value over the past week, with no recent positive news or developments to support an immediate buy signal. The long-term outlook remains unclear given the current short-term price action.

    qwen2.5:3b

Related news

  • No matched headlines yet.